Navitas Lifesciences Hiring…
EXP -0- 5 Years
Packege-3.3 Lacs to 8 lacs
Location -Bangalore. Chennai, Manipal
Job highlights
- Good Communication skills
- Time management
- Flexibility
- Problem Solving
- Quick learner
- Risk Management
Job Role
- Trainee Regulatory Associate
- Junior MICC Associate
- Bioanalytical Scientist
Responsibilities
- Manage end-to-end publishing support for IND/NDA/MAA applications and life cycle maintenance globally.
- Collaborate with various departments for submissions planning, preparation, and quality control.
- Support development of submission-ready documents for electronic submissions, including formatting and hyperlinking.
- Maintain knowledge of agency standards for regulatory submissions.
- Troubleshoot document issues and manage technical aspects of submissions.
- Perform quality checks on published outputs and ensure regulatory compliance.
- Provide training to colleagues and support data management tasks.
A Patient-Centered View of the Medication Use Process
A patient-centered view of the medication-use process focuses on the patient role
in the process. The medication-use process for noninstitutionalized patients begins
when the patient perceives a health care need or health-related problem. This is
experienced as a deviation from what is “normal” for the individual. It may be the
experience of “symptoms” or other sort of life-style interruption that challenges or
threatens the patient’s sense of well being. The patient then interprets the per
ceived problem. This interpretation is influenced by a host of psychological and
social factors unique to the individual. These include the individual’s previous expe
rience with the formal health care system; family influences; cultural differences in
the conceptualization of “health” and “illness”; knowledge of the problem (individ
uals vary greatly on the level of medical and biological knowledge); health belief
which may or may not coincide with accepted medical “truths”; psychological characteristics; personal values, motives, goals; and so on. In addition, the patient’s
interpretation may be influenced by outside forces, such as family members who
offer their own interpretations and advice.
The patient at this point may take no action to treat the condition either
because the problem is seen as minor or transitory or because the patient lacks
the means to initiate treatment. If the patient takes action, the action can include
initiation of self-treatment, initiation of contact with a nonmedical provider (such
as a faith healer), and/or contact with a health care provider. If the patient takes
action that involves contact with a health care professional, whether it is a physi
cian, pharmacist, or other health care practitioner, he must describe his “symp
tom” experience and to some extent his interpretation of that experience. In
many ways, it is at this point that control is transferred from the patient to the
professional, for it is the professional who can legitimize the experience by giving
it a name (diagnosis). Such an act, however, transforms the experience from that
with patient meaning into that with practitioner meaning (which may or may not
be shared by the patient). The quality of the professional assessment depends, in
part, on the thoroughness of the patient report, the practitioner’s skill in eliciting
relevant information, and the receptivity of the professional to “hear” information
from the patient that is potentially important. The practitioner’s skill in communicating information about the diagnosis may alter or refine the patient’s conceptual
realization of her illness experience, making the patient’s understanding more congruent
with that of the healthcare provider.